Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Genetic Lingo01:11

Genetic Lingo

Overview
The Bell Curve01:21

The Bell Curve

The normal probability distribution, often depicted as a symmetrical, bell-shaped curve, is fundamental in statistics and the study of natural phenomena. This pattern, famously described by mathematician Carl Friedrich Gauss, shows how data points are distributed around a central mean, with most values near the average and fewer observations occurring as they deviate further from it.
This pattern applies to many human characteristics beyond intelligence, such as height. For example, if you...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Effect of asthma and six-months high-intensity interval training on heart rate variability during exercise in adolescents.

Journal of sports sciences·2019
Same author

Stem cell studies advance in Britain.

The New York times on the Web·2002
Same author

An old question becomes new again: stem cell issue causes debate over the exact moment life begins.

The New York times on the Web·2002
Same author

U.S. approves labs with stem cells for research use.

The New York times on the Web·2002
Same author

For genome mappers, the tricky terrain of race requires some careful navigating.

The New York times on the Web·2002
Same author

Scientist at work: Leon Kass: moralist of science ponders its power.

The New York times on the Web·2002

関連する実験動画

Updated: Jul 11, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

ギルバート氏は,ハーバードを辞めてバイオゲンに移るかもしれない.

N Wade

    Science (New York, N.Y.)
    |October 30, 1981
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Denaturing Gradient Gel Electrophoresis (DGGE)
    10:52

    Denaturing Gradient Gel Electrophoresis (DGGE)

    Published on: February 25, 2007

    BioMEMS: Forging New Collaborations Between Biologists and Engineers
    07:26

    BioMEMS: Forging New Collaborations Between Biologists and Engineers

    Published on: November 1, 2007

    関連する実験動画

    Last Updated: Jul 11, 2026

    Ole Isacson: Development of New Therapies for Parkinson's Disease
    23:53

    Ole Isacson: Development of New Therapies for Parkinson's Disease

    Published on: April 29, 2007

    Denaturing Gradient Gel Electrophoresis (DGGE)
    10:52

    Denaturing Gradient Gel Electrophoresis (DGGE)

    Published on: February 25, 2007

    BioMEMS: Forging New Collaborations Between Biologists and Engineers
    07:26

    BioMEMS: Forging New Collaborations Between Biologists and Engineers

    Published on: November 1, 2007